Lord, Abbett & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-954,130
| Closed | -$52.3M | – | 576 |
|
|
2022
Q3 | $52.3M | Sell |
954,130
-390,953
| -29% | -$21.4M | 0.19% | 146 |
|
|
2022
Q2 | $88.9M | Buy |
+1,345,083
| New | +$88.9M | 0.31% | 87 |
|
|
2022
Q1 | – | Sell |
-30,474
| Closed | -$1.78M | – | 607 |
|
|
2021
Q4 | $1.78M | Buy |
30,474
+868
| +3% | +$50.6K | ﹤0.01% | 589 |
|
|
2021
Q3 | $1.78M | Sell |
29,606
-164
| -0.6% | -$9.85K | ﹤0.01% | 619 |
|
|
2021
Q2 | $1.78M | Buy |
29,770
+9,350
| +46% | +$560K | ﹤0.01% | 634 |
|
|
2021
Q1 | $1.02M | Sell |
20,420
-1,358,880
| -99% | -$67.5M | ﹤0.01% | 620 |
|
|
2020
Q4 | $69M | Sell |
1,379,300
-310,836
| -18% | -$15.5M | 0.18% | 178 |
|
|
2020
Q3 | $92.6M | Buy |
1,690,136
+411,008
| +32% | +$22.5M | 0.3% | 103 |
|
|
2020
Q2 | $67.7M | Buy |
1,279,128
+1,252,264
| +4,661% | +$66.2M | 0.24% | 123 |
|
|
2020
Q1 | $1.2M | Buy |
+26,864
| New | +$1.2M | 0.01% | 607 |
|
|
2015
Q2 | – | Sell |
-89,794
| Closed | -$3.07M | – | 923 |
|
|
2015
Q1 | $3.07M | Buy |
89,794
+1,374
| +2% | +$47K | 0.01% | 805 |
|
|
2014
Q4 | $3.11M | Buy |
88,420
+3,664
| +4% | +$129K | 0.01% | 807 |
|
|
2014
Q3 | $3.03M | Buy |
+84,756
| New | +$3.03M | 0.01% | 829 |
|